Organic Flower to Form Special Committee to Investigate Investments in Psychedelic Medicine, Bio-Tech and Sponsored R&D and Appoints Joe Perino as a Director

/EIN News/ -- VANCOUVER, British Columbia, June 04, 2020 (GLOBE NEWSWIRE) -- Organic Flower Investments Group Inc. (CSE: SOW)(FWB: 2K6)(OTC: QILFF) ("Organic Flower" or “OFIG” or the “Company”) today announces that it intends to form of special committee (the “Committee”) with the objective of generating measurable return on capital via the pursuit of investments in psychedelic medicine, bio-technology and sponsored R&D.

The Committee will focus on sourcing and evaluating a variety of potential investments, which may provide the Company with exposure to the following verticals:

• Novel drug discovery;
• Pre-clinical studies and clinical trials; and
• Data aggregation and monitoring platforms for psychedelic medicines.

The Company also announces that Joel Dumaresq has resigned as a director of OFIG, however he will maintain his role as Chief Executive Officer and Interim Chief Financial Officer. Furthermore, the Company is pleased to announce that it has appointed Joe Perino as a director of OFIG. Mr. Perino was the Professor Coordinator of the Police Foundations Program from 2006 to 2010. Mr. Perino has 40 years of experience with the Toronto Police Service, and possesses a proven and demonstrated understanding of police governance. From 2001 to 2005, Mr. Perino served as Staff Sergeant of the Community Response Unit and Primary Response Unit and as Detective Sergeant with the Criminal Investigation Bureau, Street Violence Task Force, Vice and Major Crime Squads.

ABOUT ORGANIC FLOWER INVESTMENTS

Organic Flower is an investment company, that specializes in investing into private and public companies engaged in a variety of industries, with a focus in the bio-medical, pharmaceutical, and naturopathic sectors, which may include medical or recreational cannabis. In particular, the investment mandate is focused on high return investment opportunities, the ability to achieve a reasonable rate of capital appreciation and to seek liquidity in our investments.

ON BEHALF OF THE ORGANIC FLOWER INVESTMENTS GROUP INC. BOARD OF DIRECTORS

“Joel Dumaresq”

Joel Dumaresq
CEO, Director
+1 (604) 687-2038
info@sowcannabis.ca

Learn more about Organic Flower by visiting our website at: https://sowcannabis.ca/

THE CSE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.

Notice Regarding Forward Looking Information:

This news release contains certain "forward-looking information" within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or information that certain events or conditions "may" or "will" occur. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking information throughout this news release. Forward-looking information includes, but is not limited to: political changes in Canada and internationally, future legislative and regulatory developments involving cannabis in Canada and internationally, AgraFlora’s ability to secure distribution channels in international jurisdictions, competition and other risks affecting AgraFlora in particular and the cannabis industry generally. Without limiting the generality of the foregoing, the forward-looking statements herein include, among other things, AgraFlora’s ability to develop the Delta Greenhouse Complex and the successful integration of Organic Flower’s unique domestic downstream asset portfolio under the AgraFlora banner.

The forward-looking information contained in this release is expressly qualified by the foregoing cautionary statements and is made as of the date of this release. Except as may be required by applicable securities laws, the Company does not undertake any obligation to publicly update or revise any forward-looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise.